TKI Selection Is Critical in Reducing Cardiovascular Risk in Patients With CML
Management of cardiovascular risk factors in patients with chronic myeloid leukemia on TKI therapy...
Read MoreOct 3, 2023
Management of cardiovascular risk factors in patients with chronic myeloid leukemia on TKI therapy...
Read MoreOct 2, 2023
Hospitalized patients with leukemia had the highest percentages of secondary hypertension, followed by those patients with non-Hodgkin lymphoma, according to a study published in Chronic Illness. Chanhyun Park, PhD, MPharm, MEd,...
Read MoreOct 1, 2023
In most patients with acute myeloid leukemia (AML), intrathecal therapy (IT) chemotherapy was efficacious in eliminating cerebrospinal fluid (CSF) blasts and improving neurologic symptoms, according to a study published in...
Read MoreSep 30, 2023
Patient care is frequently accompanied by emotional and stressful situations. Managing patient–physician relationships, negotiating with employers, and long work hours can create a heavy burden on healthcare workers. In the past...
Read MoreSep 29, 2023
For patients with suspected myelodysplastic neoplasms (MDS), diagnoses are often discordant for...
Read MoreSep 28, 2023
Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related...
Read More